In 2009 Pfizer WAS the largest case in American Healthcare.
PFIZER CRIMINAL CASE
BEXTRA CELEBREX -BOTH are “COX-2” selective non-steroidal anti-inflammatory drug – BEXTRA was removed from market CELEBREX AKA CELECOXIB
PRESCRIBED FOR JUVENILE RHEUMATOID ARTHRITIS
Celebrex is used to treat juvenile rheumatoid arthritis in children as young as 2 years old.
It is also used in the treatment of hereditary polyps in the colon.
CELECOXIB WARNING OF HEART ATTACK
Celecoxib can increase your risk of fatal heart attack or stroke, even if you don’t have any risk factors. Do not use Celebrex just before or after heart bypass surgery (coronary artery bypass graft, or CABG).
Pharmacia & Upjohn Company has agreed to plead guilty to a felony violation of the Food, Drug and Cosmetic Act for misbranding Bextra with the intent to defraud or mislead.
Justice Dept

Johnson and Johnson CRIMINAL CASE
RISPERDAL
Johnson and Johnson paid Doctors to prescribe unapproved dangerous drug to the “most vulnerable
Justice Dept
– The elderly in nursing homes, Children and those with mental disabilities…”

https://www.justice.gov/opa/pr/johnson-johnson-pay-more-22-billion-resolve-criminal-and-civil-investigations
The Justice Department wrote :
“In a plea agreement resolving these charges, Janssen admitted that it promoted Risperdal to health care providers for treatment of psychotic symptoms and associated behavioral disturbances exhibited by elderly, non-schizophrenic dementia patients. Under the terms of the plea agreement, Janssen will pay a total of $400 million, including a criminal fine of $334 million and forfeiture of $66 million.
Full Text

GLAXO SMITH KLINE CRIMINAL CASE
PAXIL WELLBUTRIN AVANDIA
Paxil and Wellbutrin, into interstate commerce and one count of failing to report safety data about the drug Avandia to the Food and Drug Administration (FDA). Under the terms of the plea agreement, GSK will pay a total of $1 billion, including a criminal fine of $956,814,400 and forfeiture in the amount of $43,185,600. The criminal plea agreement also includes certain non-monetary compliance commitments and certifications by GSK’s U.S. president



Pfizer, Johnson and Johnson and Glaxo Smith Kline have been FINED Billions of Dollars
